Skip to main navigation Skip to search Skip to main content

BH3 domain mutation of proapoptotic genes Bad, Bmf and Bcl-G is rare in transitional cell carcinomas of the urinary bladder

  • The Catholic University of Korea, College of Medicine

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Aims: Mounting evidence indicates that deregulation of apoptosis contributes to the development of human cancers. Bcl-2 family proteins regulate the intrinsic apoptosis pathway. The aim of this study was to explore the possibility that mutation of BH3 domain of proapoptotic Bcl-2 genes Bad, Bmf and Bcl-G might be involved in the development of urinary bladder cancer. Methods: We analysed the BH3 domains of Bad, Bmf and Bcl-G genes for the detection of somatic mutations in 43 transitional cell carcinomas (TCCs) of the urinary bladder by a single strand conformation polymorphism assay in this study. Results: There was no somatic mutation of BH3 domains of Bad, Bmf and Bcl-G genes in the TCC samples. Conclusion: The data presented here indicate that BH3 domain mutation of these genes is rare in TCCs and may not contribute to the pathogenesis of TCCs.

Original languageEnglish
Pages (from-to)33-34
Number of pages2
JournalPathology
Volume38
Issue number1
DOIs
StatePublished - Feb 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Apoptosis
  • BH3 domain
  • Bladder cancer
  • Mutation
  • Transitional cell carcinoma

Fingerprint

Dive into the research topics of 'BH3 domain mutation of proapoptotic genes Bad, Bmf and Bcl-G is rare in transitional cell carcinomas of the urinary bladder'. Together they form a unique fingerprint.

Cite this